参考文献/References:
1 周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,2003.85.
2 Galimberti S,Marchetti A,Buttitta F,et al.Multidrug resistance related genes and p53 expression in human NSCLC[J].Anticancer Res,1998,18(4C):2973-2976.
3 Trock BJ,Ceonessa F,Clarke R,et al.Multidrug resistance in breast cancer:A Meta-analysis of MDR1/gp-170 expression and its possible fuctional significance[J].J Natl Cancer Inst,1997,89:917-931.
4 王树滨,刘雅洁,隋广杰等.P-糖蛋白在乳腺癌组织中的表达与预后的关系[J].中国肿瘤临床,2001,28(5):325-328.
5 Cordobes MD,Starze A,Delmon-Moingeon L,et al.Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells:Corre lation with mdr gene expression[J].J Nucl Med,1996,37:286-289.
6 Vecchio SD,Ciarmiello A,Leonardo P,et al.Fractional retention of the technetium-99m-sestamibi as an index of P-glycoprotein rxpres-sion in untreated breast cancer patients[J].J Nucl Med,1997,38(9):1348-1351.
7 Kostakoglu L,Elahi N,Kiratli P,et al.Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors[J].J Nucl Med,1997,38(7):1003-1008.
8 Nishiyama Y,Kawasaki Y,Yamamoto Y,et al.Technetium-99m-MIBI and thailium-201 scimtigraphy of primary lung cancer[J].J Nucl Med,1997,38(9):1358-1361.
9 Chia-Hung K,Shih-Chuan T,Liu TG,et al.P-glycpprotein and multidrug-related protein expressions in relation to technetium-99m methoxyisobutylisonitrile scintimammorgraphy findings[J].Cancer Res,2001,15(61):1412-1414.
10 Shung-Shung S,Tih-Fang H,Shih-chuan T,et al.Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results[J].Cancer Lett,2000,153(1-2):95-100.
11 Del-Vecchio S,Ciarmiello A,Pue L,et al.Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients[J].J Nucl Med,1997,38(9):1348-1351.
12 Del-Vecchio S,Ciarmiello A,Potena MI,et al.In Vivo detection of multidrug-resistance (MDR1) phenotype by technetium-99m ses-tamibi scan in untreated breast cancer patients[J].Eur J Nucl Med,1997,24(2):150-159.
13 Muriel A,Noreli F,Jean-Marc R,et al.Enhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer[J].Breast Cancer Res Trea,2000,61(1):13-20.
14 Van de Vijver MJ,He YD,vant Veer LJ,et al.A gene-expression signature as a predictor of survival in breast cancer[J].Engl J Med,2002,347(25):1999-2009.
相似文献/References:
[1]白旭东,唐志刚,王学斌.99Tcm标记异腈类配合物的研究进展[J].国际放射医学核医学杂志,2005,29(1):19.
BAI Xu-dong,TANG Zhi-gang,WANG Xue-bin.The development of 99Tcm labeled isonitrile complexes[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):19.
[2]黄建敏,曲雁,潘莉萍.恶性骨肿瘤多药耐药的99Tcm-MIBI体层显像研究[J].国际放射医学核医学杂志,2005,29(4):169.
HUANG Jian-min,QU Yan,PAN Li-ping.Research of 99Tcm-MIBI SPECT imaging for assessment of multidrug resistance in Bone tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(6):169.
[3]程兵.99Tcm-MIBI显像检测乳腺癌多药耐药[J].国际放射医学核医学杂志,2002,26(2):67.
CHENG Bing.The appliciation of 99Tcm-MIBI scintimammography to diagnose multidrug resistance of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(6):67.
[4]钱习军.99Tcm-MIBI显像对肿瘤多药耐药检测的应用[J].国际放射医学核医学杂志,2002,26(4):173.
QIAN Xi-jun.The application of 99Tcm-MIBI imaging to detect multidrug resistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2002,26(6):173.
[5]白景明,李亚明.体内多药耐药的显像研究[J].国际放射医学核医学杂志,1999,23(5):208.